Reference
Hidalgo-Tenorio C, et al. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci. International Journal of Antimicrobial Agents 62: No. 3, Sep 2023. Available from: URL: https://www.elsevier.com/locate/ijantimicag
Rights and permissions
About this article
Cite this article
Antibacterials. Reactions Weekly 1980, 39 (2023). https://doi.org/10.1007/s40278-023-48231-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-48231-4